|
Volumn 13, Issue 3, 2006, Pages 3139-3146
|
Prospective evaluation of the prevalence and severity of fatigue in patients with prostate cancer undergoing radical external beam radiotherapy and neoadjuvant hormone therapy.
a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;
PROSTATE SPECIFIC ANTIGEN;
ADJUVANT THERAPY;
AGED;
ARTICLE;
BLOOD;
CANCER STAGING;
FATIGUE;
HUMAN;
MALE;
MIDDLE AGED;
MULTIMODALITY CANCER THERAPY;
PREVALENCE;
PROSPECTIVE STUDY;
PROSTATE TUMOR;
QUALITY OF LIFE;
QUESTIONNAIRE;
STATISTICAL MODEL;
WALKING;
AGED;
AGED, 80 AND OVER;
ANTINEOPLASTIC AGENTS, HORMONAL;
COMBINED MODALITY THERAPY;
FATIGUE;
HUMANS;
LINEAR MODELS;
MALE;
MIDDLE AGED;
NEOADJUVANT THERAPY;
NEOPLASM STAGING;
PREVALENCE;
PROSPECTIVE STUDIES;
PROSTATE-SPECIFIC ANTIGEN;
PROSTATIC NEOPLASMS;
QUALITY OF LIFE;
QUESTIONNAIRES;
WALKING;
|
EID: 33747593280
PISSN: 11959479
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (23)
|
References (0)
|